CIK: 0001697013
Total reported value
$1.9B
Reporting period: 2026-03-31 · Number of holdings: 120
Eversept Partners, LP disclosed 120 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $1.9B and a quarterly turnover rate of 64.4%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "E"
Eversept Partners, LP's disclosed holdings carry a Herfindahl concentration index of 0.032 — mathematically equivalent to about 31 equally-sized positions, well below its 120 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.67), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 44% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim VERA
-29.3% -$68.2M
Add BKD
+851.8% $44.8M
Add SPY
+138.3% $39.0M
Add UTHR
+4.6% $33.6M
Trim VRDN
-60.0% -$41.5M
Trim BRKR
-85.1% -$32.7M
Showing top 117 holdings (of 120 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | UTHR | United Therapeutics CORP | Stock-Healthcare | 8.26% | +2.06% | +4.62% | |
| 2 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 7.26% | — | +6.09% | |
| 3 | ABVX | Abivax Sa-adr | Stock-Other | 5.49% | +1.02% | +42.05% | |
| 4 | GSK | Gsk Plc-spon Adr | Stock-Healthcare | 5.20% | -1.42% | -33.38% | |
| 5 | VERA | Vera Therapeutics INC | Stock-Other | 4.61% | -3.23% | -29.26% | |
| 6 | NTRA | Natera INC | Stock-Healthcare | 4.06% | — | +15.01% | |
| 7 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 3.67% | +2.13% | +138.31% | |
| 8 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 3.55% | — | -12.94% | |
| 9 | CLDX | Celldex Therapeutics INC | Stock-Other | 2.99% | +1.03% | +24.62% | |
| 10 | PCVX | Vaxcyte INC | Stock-Other | 2.83% | — | -22.84% | |
| 11 | BKD | Brookdale Senior Living INC | Stock-Other | 2.57% | +2.37% | +851.79% | |
| 12 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 2.50% | — | +17.44% | |
| 13 | QGEN | Qiagen N.V. | Stock-Healthcare | 2.16% | +2.16% | NEW | |
| 14 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 2.12% | +2.12% | NEW | |
| 15 | HCA | Hca Healthcare INC | Stock-Healthcare | 1.98% | — | -17.36% | |
| 16 | TLT | Ishares 20+ Year Treasury Bd | ETF-Gov Bonds | 1.96% | +0.95% | +86.43% | |
| 17 | WELL | Welltower INC | Stock-Real Estate | 1.89% | +1.89% | NEW | |
| 18 | DOC | Healthpeak Properties INC | Stock-Real Estate | 1.72% | +1.72% | NEW | |
| 19 | PODD | Insulet CORP | Stock-Healthcare | 1.59% | +0.52% | +92.14% | |
| 20 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 1.53% | — | +1.57% | |
| 21 | GERN | Geron CORP | Stock-Other | 1.48% | — | +6.65% | |
| 22 | OHI | Omega Healthcare Investors | Stock-Real Estate | 1.35% | +1.35% | NEW | |
| 23 | LQDA | Liquidia CORP | Stock-Other | 1.35% | — | +32.97% | |
| 24 | CYH | Community Health Systems INC | Stock-Other | 1.35% | — | +9.23% | |
| 25 | AVTR | Avantor INC | Stock-Healthcare | 1.23% | -0.60% | -6.37% | |
| 26 | EHC | Encompass Health CORP | Stock-Healthcare | 0.99% | — | +81.53% | |
| 27 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.92% | — | +78.86% | |
| 28 | TVTX | Travere Therapeutics INC | Stock-Other | 0.85% | -1.41% | -53.82% | |
| 29 | INSM | Insmed INC | Stock-Healthcare | 0.81% | +0.81% | NEW | |
| 30 | CTMX | Cytomx Therapeutics INC | Stock-Other | 0.79% | — | +27.18% | |
| 31 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 0.76% | +0.76% | NEW | |
| 32 | RGEN | Repligen CORP | Stock-Healthcare | 0.75% | +0.75% | NEW | |
| 33 | BBNX | Beta Bionics INC | Stock-Other | 0.75% | — | +108.60% | |
| 34 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.74% | -2.05% | -59.98% | |
| 35 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 0.72% | — | +32.66% | |
| 36 | ARDX | Ardelyx INC | Stock-Other | 0.70% | — | +29.99% | |
| 37 | LTC | Ltc Properties INC | Stock-Other | 0.63% | +0.63% | NEW | |
| 38 | BMRN | Biomarin Pharmaceutical INC | Stock-Healthcare | 0.62% | — | +121.62% | |
| 39 | CHE | Chemed CORP | Stock-Healthcare | 0.62% | +0.62% | NEW | |
| 40 | PHVS | Pharvaris N.V. | Stock-Other | 0.61% | — | -7.34% | |
| 41 | UNH | Unitedhealth Group INC | Stock-Healthcare | 0.57% | -0.44% | -34.28% | |
| 42 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 0.52% | +0.52% | NEW | |
| 43 | PNTG | Pennant Group Inc/the | Stock-Other | 0.50% | — | +6.20% | |
| 44 | XLK | Ss Technology Select Sector | ETF-Tech | 0.49% | +0.49% | NEW | |
| 45 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.48% | — | -32.09% | |
| 46 | PALI | Palisade Bio INC | Stock-Other | 0.46% | — | -7.49% | |
| 47 | MRNA | Moderna INC | Stock-Healthcare | 0.43% | — | -40.37% | |
| 48 | VKTX | Viking Therapeutics INC | Stock-Healthcare | 0.41% | — | — | |
| 49 | ICLR | ICON Public Limited Company | Stock-Healthcare | 0.40% | -0.48% | -28.32% | |
| 50 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 0.40% | — | -44.00% |
Performance for Q3 2026
+12.4%
Performance Last 4 Quarters
+62.1%
Based on 79% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 120 | $1.9B | 64 | |
| 2025-12-31 | 107 | $2.0B | 58 | |
| 2025-09-30 | 86 | $1.5B | 82 | |
| 2025-06-30 | 68 | $1.1B | 0 | |
| 2025-03-31 | 57 | $984.7M | 100 | |
| 2024-12-31 | 65 | $1.1B | 0 | |
| 2024-09-30 | 67 | $1.5B | 0 | |
| 2024-06-30 | 74 | $1.5B | 0 | |
| 2024-03-31 | 70 | $1.5B | 0 | |
| 2023-12-31 | 57 | $1.1B | 0 | |
| 2023-09-30 | 69 | $1.2B | 0 | |
| 2023-06-30 | 71 | $1.2B | 0 | |
| 2023-03-31 | 62 | $1.4B | 0 | |
| 2022-12-31 | 64 | $1.1B | 0 | |
| 2022-09-30 | 69 | $1.2B | 0 | |
| 2022-06-30 | 76 | $1.4B | 0 | |
| 2022-03-31 | 86 | $1.3B | 0 | |
| 2021-12-31 | 105 | $1.6B | 0 | |
| 2021-09-30 | 102 | $1.4B | 0 | |
| 2021-06-30 | 87 | $1.5B | 0 | |
| 2021-03-31 | 83 | $1.3B | 0 | |
| 2020-12-31 | 60 | $851.9M | 0 | |
| 2020-09-30 | 48 | $449.4M | 0 | |
| 2020-06-30 | 69 | $729.3M | 0 | |
| 2020-03-31 | 61 | $402.3M | 0 | |
| 2019-12-31 | 72 | $566.3M | 0 | |
| 2019-09-30 | 57 | $322.4M | 0 | |
| 2019-06-30 | 62 | $357.1M | 0 | |
| 2019-03-31 | 52 | $342.8M | 0 | |
| 2018-12-31 | 54 | $184.7M | 0 | |
| 2018-09-30 | 63 | $227.9M | 0 | |
| 2018-06-30 | 72 | $218.6M | 0 | |
| 2018-03-31 | 57 | $215.3M | 0 | |
| 2017-12-31 | 46 | $173.8M | 0 |
Eversept Partners, LP's most significant position changes for 2026-03-31: Sold out: Danaher CORP (DHR); New buy: Qiagen N.V. (QGEN); New buy: Vertex Pharmaceuticals INC (VRTX); New buy: Welltower INC (WELL); New buy: Healthpeak Properties INC (DOC).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BKD | Brookdale Senior Living INC | +2.4% | +851.79% | Add |
| 2 | SPY | Ss Spdr S&p 500 ETF Trust-us | +2.1% | +138.31% | Add |
| 3 | UTHR | United Therapeutics CORP | +2.1% | +4.62% | Add |
| 4 | CLDX | Celldex Therapeutics INC | +1% | +24.62% | Add |
| 5 | ABVX | Abivax Sa-adr | +1% | +42.05% | Add |
| 6 | TLT | Ishares 20+ Year Treasury Bd | +1% | +86.43% | Add |
| 7 | PODD | Insulet CORP | +0.5% | +92.14% | Add |
| 8 | RVTY | Revvity INC | -0.4% | -47.87% | Trim |
| 9 | XBI | Ss Spdr S&p Biotech ETF | -0.4% | -69.82% | Trim |
| 10 | UNH | Unitedhealth Group INC | -0.4% | -34.28% | Trim |
| 11 | ESPR | Esperion Therapeutics INC | -0.5% | -54.92% | Trim |
| 12 | ICLR | ICON Public Limited Company | -0.5% | -28.32% | Trim |
| 13 | CNC | Centene CORP | -0.5% | -65.55% | Trim |
| 14 | GKOS | Glaukos CORP | -0.5% | -59.17% | Trim |
| 15 | AVTR | Avantor INC | -0.6% | -6.37% | Trim |
| 16 | HQY | Healthequity INC | -0.6% | -72.21% | Trim |
| 17 | TECH | Bio-techne CORP | -0.8% | -66.64% | Trim |
| 18 | TVTX | Travere Therapeutics INC | -1.4% | -53.82% | Trim |
| 19 | GSK | Gsk Plc-spon Adr | -1.4% | -33.38% | Trim |
| 20 | BRKR | Bruker CORP | -1.6% | -85.07% | Trim |
| 21 | VRDN | Viridian Therapeutics INC | -2.1% | -59.98% | Trim |
| 22 | VERA | Vera Therapeutics INC | -3.2% | -29.26% | Trim |
| 23 | DHR | Danaher CORP | — | EXIT | Sold out |
| 24 | QGEN | Qiagen N.V. | — | NEW | New buy |
| 25 | VRTX | Vertex Pharmaceuticals INC | — | NEW | New buy |
| 26 | WELL | Welltower INC | — | NEW | New buy |
| 27 | DOC | Healthpeak Properties INC | — | NEW | New buy |
| 28 | OHI | Omega Healthcare Investors | — | NEW | New buy |
| 29 | EXK | Exact Sciences CORP | — | EXIT | Sold out |
| 30 | CDTX | Cidara Therapeutics INC | — | EXIT | Sold out |
| 31 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | Sold out |
| 32 | INSM | Insmed INC | — | NEW | New buy |
| 33 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | — | NEW | New buy |
| 34 | RGEN | Repligen CORP | — | NEW | New buy |
| 35 | BIIB | Biogen INC | — | EXIT | Sold out |
| 36 | SEM | Select Medical Holdings CORP | — | EXIT | Sold out |
| 37 | CGON | Cg Oncology INC | — | EXIT | Sold out |
| 38 | BMY | Bristol-myers Squibb Co | — | EXIT | Sold out |
| 39 | LTC | Ltc Properties INC | — | NEW | New buy |
| 40 | CHE | Chemed CORP | — | NEW | New buy |
| 41 | ELV | Elevance Health INC | — | EXIT | Sold out |
| 42 | MNKD | Mannkind CORP | — | EXIT | Sold out |
| 43 | ASND | Ascendis Pharma A/S | — | EXIT | Sold out |
| 44 | ILMN | Illumina INC | — | EXIT | Sold out |
| 45 | IWM | Ishares Russell 2000 ETF | — | NEW | New buy |
| 46 | DVAX | Dynavax Technologies CORP | — | EXIT | Sold out |
| 47 | XLK | Ss Technology Select Sector | — | NEW | New buy |
| 48 | EWTX | Edgewise Therapeutics INC | — | EXIT | Sold out |
| 49 | CPRX | Catalyst Pharmaceuticals INC | — | EXIT | Sold out |
| 50 | HUM | Humana INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-09-30 | 2021-11-15 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-06-30 | 2021-08-16 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2021-03-31 | 2021-05-13 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-09-30 | 2020-11-13 | Amendment | View on EDGAR |
| 2020-09-30 | 2020-11-12 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-06-30 | 2020-08-13 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2020-03-31 | 2020-05-13 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2019-12-31 | 2020-02-13 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2019-09-30 | 2019-11-13 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2019-06-30 | 2019-10-30 | Amendment | View on EDGAR |
| 2019-06-30 | 2019-08-13 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2019-03-31 | 2019-05-14 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2018-12-31 | 2019-02-13 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2023-11-08 | Amendment | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2018-03-31 | 2018-05-14 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2023-11-08 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-02-13 | Amendment | View on EDGAR |
| 2017-12-31 | 2018-02-12 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001741001
Total reported value
$1.9B
118 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0000943656
Total reported value
$1.9B
416 stks
2018-03-31
Stale — no recent filing
AUM within 0.1% of this institution
CIK 0001085163
Total reported value
$1.9B
194 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001993440
Total reported value
$895.1M
33 stks
2026-03-31
2 of the top 5 holdings overlap, including United Therapeutics CORP
CIK 0002026172
Total reported value
$587.7M
144 stks
2026-03-31
2 of the top 5 holdings overlap, including United Therapeutics CORP
CIK 0000009015
Total reported value
$6.2B
238 stks
2026-03-31
1 of the top 5 holdings overlap, including Invesco Qqq Trust Series 1